Allelic variations in superoxide dismutase-1 (SOD1) gene and renal and cardiovascular morbidity and mortality in type 2 diabetic subjects

Molecular Genetics and Metabolism

Volumn 106, Issue 3, 2012, Pages 359-365

  Neves, Ana Luísa ^a,b   Mohammedi, Kamel ^a,c   Emery, Nathalie ^a,d   Roussel, Ronan ^c,d,e   Fumeron, Frédéric ^a,d   Marre, Michel ^a,c,d   Velho, Gilberto ^a  

^a INSERM   (France)

^b University of Porto   (Portugal)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Cardiovascular complications; Diabetic nephropathy; Genetic epidemiology; Oxidative stress; Sudden death; Superoxide dismutase

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; CREATININE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUCASIAN; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC VARIABILITY; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; STROKE; SUDDEN DEATH;

AGED; ALBUMINURIA; ALLELES; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GENETIC VARIATION; HUMANS; KIDNEY; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SUPEROXIDE DISMUTASE;

EID: 84862570716     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2012.04.023     Document Type: Article

References (36)

1. Kannel W.B., McGee D.L. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979, 241:2035-2038.
2. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 1998, 339:229-234.
3. Balkau B., Jouven X., Ducimetiere P., Eschwege E. Diabetes as a risk factor for sudden death. Lancet 1999, 354:1968-1969.
4. Stengel B., Billon S., Van Dijk P.C., Jager K.J., Dekker F.W., Simpson K., Briggs J.D. Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. Nephrol. Dial. Transplant. 2003, 18:1824-1833.
5. Jones C.A., Krolewski A.S., Rogus J., Xue J.L., Collins A., Warram J.H. Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause?. Kidney Int. 2005, 67:1684-1691.
6. Rossing P., Hougaard P., Borch-Johnsen K., Parving H.H. Predictors of mortality in insulin dependent diabetes: 10year observational follow up study. BMJ 1996, 313:779-784.
7. Valmadrid C.T., Klein R., Moss S.E., Klein B.E. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch. Intern. Med. 2000, 160:1093-1100.
8. Young I.S., Woodside J.V. Antioxidants in health and disease. J. Clin. Pathol. 2001, 54:176-186.
9. Guidot D.M., McCord J.M., Wright R.M., Repine J.E. Absence of electron transport (Rho 0 state) restores growth of a manganese-superoxide dismutase-deficient Saccharomyces cerevisiae in hyperoxia. Evidence for electron transport as a major source of superoxide generation in vivo. J. Biol. Chem. 1993, 268:26699-26703.
10. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
11. Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 2002, 23:599-622.
12. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005, 54:1615-1625.
13. Forbes J.M., Coughlan M.T., Cooper M.E. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008, 57:1446-1454.
14. Hopps E., Noto D., Caimi G., Averna M.R. A novel component of the metabolic syndrome: the oxidative stress. Nutr. Metab. Cardiovasc. Dis. 2010, 20:72-77.
15. Heistad D.D. Oxidative stress and vascular disease: 2005 Duff lecture. Arterioscler. Thromb. Vasc. Biol. 2006, 26:689-695.
16. Mehta J.L., Rasouli N., Sinha A.K., Molavi B. Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction. Int. J. Biochem. Cell Biol. 2006, 38:794-803.
17. Fridovich I. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 1995, 64:97-112.
18. Marklund S.L. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem. J. 1984, 222:649-655.
19. Faraci F.M., Didion S.P. Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1367-1373.
20. Al-Kateb H., Boright A.P., Mirea L., Xie X., Sutradhar R., Mowjoodi A., Bharaj B., Liu M., Bucksa J.M., Arends V.L., Steffes M.W., Cleary P.A., Sun W., Lachin J.M., Thorner P.S., Ho M., McKnight A.J., Maxwell A.P., Savage D.A., Kidd K.K., Kidd J.R., Speed W.C., Orchard T.J., Miller R.G., Sun L., Bull S.B., Paterson A.D. Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics Study. Diabetes 2008, 57:218-228.
21. Mohammedi K., Maimaitiming S., Emery N., Bellili-Munoz N., Roussel R., Fumeron F., Hadjadj S., Marre M., Velho G. Allelic variations in superoxide dismutase-1 (SOD1) gene are associated with increased risk of diabetic nephropathy in type 1 diabetic subjects. Mol. Genet. Metab. 2011, 104:654-660.
22. Lievre M., Marre M., Chatellier G., Plouin P., Reglier J., Richardson L., Bugnard F., Vasmant D. The non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and ramipril (DIABHYCAR) study: design, organization, and patient recruitment. DIABHYCAR Study Group. Control. Clin. Trials 2000, 21:383-396.
23. Marre M., Lievre M., Chatellier G., Mann J.F., Passa P., Menard J. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study). BMJ 2004, 328:495.
24. Marre M., Claudel J.P., Ciret P., Luis N., Suarez L., Passa P. Laser immunonephelometry for routine quantification of urinary albumin excretion. Clin. Chem. 1987, 33:209-213.
25. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann. Intern. Med. 1999, 130:461-470.
26. Milani P., Gagliardi S., Cova E., Cereda C. SOD1 transcriptional and posttranscriptional regulation and its potential implications in ALS. Neurol. Res. Int. 2011, 2011:458427.
27. Cheverud J.M. A simple correction for multiple comparisons in interval mapping genome scans. Heredity 2001, 87:52-58.
28. Nyholt D.R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet. 2004, 74:765-769.
29. 2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice. Diabetes 2001, 50:2114-2125.
30. DeRubertis F.R., Craven P.A., Melhem M.F., Salah E.M. Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction. Diabetes 2004, 53:762-768.
31. DeRubertis F.R., Craven P.A., Melhem M.F. Acceleration of diabetic renal injury in the superoxide dismutase knockout mouse: effects of tempol. Metabolism 2007, 56:1256-1264.
32. Higashi Y., Noma K., Yoshizumi M., Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ. J. 2009, 73:411-418.
33. Heitzer T., Schlinzig T., Krohn K., Meinertz T., Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001, 104:2673-2678.
34. Tanaka M., Mokhtari G.K., Terry R.D., Balsam L.B., Lee K.H., Kofidis T., Tsao P.S., Robbins R.C. Overexpression of human copper/zinc superoxide dismutase (SOD1) suppresses ischemia-reperfusion injury and subsequent development of graft coronary artery disease in murine cardiac grafts. Circulation 2004, 110:II-200-II-206.
35. Yoshida T., Maulik N., Engelman R.M., Ho Y.S., Das D.K. Targeted disruption of the mouse Sod I gene makes the hearts vulnerable to ischemic reperfusion injury. Circ. Res. 2000, 86:264-269.
36. Zhang Y.E., Fu S.Z., Li X.Q., Chen P., Wang J.L., Che J., Tang J.M., Chen S.Y., Wang J.N. PEP-1-SOD1 protects brain from ischemic insult following asphyxial cardiac arrest in rats. Resuscitation 2011, 82:1081-1086.